We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+16.39%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$6.4B
AUM Growth
+$319M
Cap. Flow
-$190M
Cap. Flow %
-2.98%
Top 10 Hldgs %
23.07%
Holding
289
New
50
Increased
129
Reduced
80
Closed
21

Top Sells

Rank Stock Value
1
INSM icon
Insmed
INSM
+$95.2M
2
VRNA
Verona Pharma
VRNA
+$72.7M
3
GH icon
Guardant Health
GH
+$72.5M
4
CELC icon
Celcuity
CELC
+$63.7M
5
EVH icon
Evolent Health
EVH
+$53.2M

Sector Composition

Rank Sector Weight
1 Healthcare 42.37%
2 Industrials 17.69%
3 Technology 15.85%
4 Consumer Discretionary 6.94%
5 Utilities 5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHI icon
26
D.R. Horton
DHI
$41.2B
$61.5M 0.96%
427,045
-28,629
-6% -$4.36M
BLTE
27
Belite Bio
BLTE
$6.11B
$61.3M 0.96%
383,091
+187,779
+96% +$22.2M
KLAC icon
28
KLA
KLAC
$229B
$55.2M 0.86%
452,820
-12,670
-3% -$1.49M
SITM icon
29
SiTime
SITM
$16.8B
$55.1M 0.86%
155,983
+375
+0.2% +$117K
WCN
30
Waste Connections
WCN
$41.7B
$54.4M 0.85%
310,111
+590
+0.2% +$102K
RBA icon
31
RB Global
RBA
$15.9B
$54.3M 0.85%
527,595
+1,276
+0.2% +$130K
PLD icon
32
Prologis
PLD
$134B
$53.9M 0.84%
420,834
+70,764
+20% +$8.82M
NVT icon
33
nVent Electric
NVT
$24B
$52.6M 0.82%
514,890
-26,443
-5% -$2.75M
LAD icon
34
Lithia Motors
LAD
$8.14B
$52M 0.81%
156,374
-24,801
-14% -$7.88M
RPRX icon
35
Royalty Pharma
RPRX
$27.1B
$50.2M 0.78%
1,296,826
+380,337
+41% +$14.5M
ORLY icon
36
O'Reilly Automotive
ORLY
$71.6B
$49.4M 0.77%
541,867
+8,781
+2% +$858K
KYMR icon
37
Kymera Therapeutics
KYMR
$9.82B
$48.7M 0.76%
626,430
-18,160
-3% -$1.23M
STE icon
38
Steris
STE
$22.8B
$48.3M 0.75%
190,483
+15,416
+9% +$3.87M
VMC icon
39
Vulcan Materials
VMC
$35.6B
$48.3M 0.75%
169,367
+1,413
+0.8% +$415K
GLBE icon
40
Global E Online
GLBE
$6.71B
$47.9M 0.75%
1,217,689
+2,160
+0.2% +$80.1K
WMB icon
41
Williams Companies
WMB
$90.2B
$47.7M 0.74%
793,160
-292,077
-27% -$17.7M
NI icon
42
NiSource
NI
$19.5B
$47.3M 0.74%
1,133,220
+562,451
+99% +$24M
DTM icon
43
DT Midstream
DTM
$13.2B
$47.3M 0.74%
394,724
+211,471
+115% +$24.3M
TLN
44
Talen Energy Corp
TLN
$14.2B
$46.7M 0.73%
124,596
+12,837
+11% +$4.99M
CHWY icon
45
Chewy
CHWY
$9.52B
$46.7M 0.73%
1,412,717
+3,573
+0.3% +$124K
LSCC icon
46
Lattice Semiconductor
LSCC
$16.2B
$45.7M 0.71%
621,156
+11,068
+2% +$788K
IONS icon
47
Ionis Pharmaceuticals
IONS
$10.1B
$45.5M 0.71%
+575,000
New +$43.3M
NVDA icon
48
NVIDIA
NVDA
$5.25T
$44.7M 0.7%
239,284
+745
+0.3% +$139K
CLDX icon
49
Celldex Therapeutics
CLDX
$3.07B
$44.6M 0.7%
1,642,559
-216,536
-12% -$5.7M
ROL icon
50
Rollins
ROL
$17.5B
$44.4M 0.69%
739,746
+20,699
+3% +$1.22M

Similar funds

Eventide Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Eventide Asset Management held 289 positions worth $6.4B, up 5.3% from $6.08B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Eventide Asset Management's Q4 2025 filing shows 50 new, 129 increased, 80 reduced and 21 closed positions. Its largest new stake was Ionis Pharmaceuticals: 575,000 shares worth $45.5M. The largest sale was Insmed, an estimated $95.2M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 38% a quarter earlier, followed by Industrials and Technology.

  • Eventide Asset Management's largest Q4 2025 buy was Ionis Pharmaceuticals: 575,000 shares worth $45.5M.
  • Eventide Asset Management added most to Monolithic Power Systems in Q4 2025, an estimated $26.1M increase.
  • Eventide Asset Management's biggest Q4 2025 reduction was Insmed, cutting an estimated $95.2M.
  • Eventide Asset Management fully exited Verona Pharma in Q4 2025, selling an estimated $72.7M.
  • Eventide Asset Management's ten largest holdings make up 23% of its $6.4B portfolio in Q4 2025.
  • Eventide Asset Management opened 50 new positions and closed 21 in Q4 2025.
  • Eventide Asset Management's portfolio value rose 5.3% quarter-over-quarter to $6.4B.

Based on Eventide Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.